Principal Financial Group’s CureVac CVAC Stock Holding History

Principal Financial Group’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,970	Closed	-$205K	–	2560
2021 Q4	$205K	Buy	+5,970	New	+$240K	﹤0.01%	2359

Other funds holding CVAC

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Principal Financial Group's CVAC Position: Q1 2022 in Review

Principal Financial Group sold out of CureVac (CVAC) in Q1 2022, closing a stake of 5,970 shares — an estimated $205K sold.

Principal Financial Group first reported a position in CVAC in Q4 2021 and held it in 1 quarter. The position peaked at $205K in Q4 2021. 111 funds tracked by Wall St. Rank hold CVAC as of Q1 2022.

Principal Financial Group reported no remaining CureVac position as of Q1 2022 after selling out during the quarter.
Principal Financial Group sold 5,970 CureVac shares in Q1 2022, an estimated $205K.
Principal Financial Group first reported a position in CureVac in Q4 2021 and held it in 1 quarter.
Principal Financial Group's CureVac position peaked at $205K in Q4 2021.
111 funds tracked by Wall St. Rank held CureVac as of Q1 2022.

Based on Principal Financial Group's 13F filing for Q1 2022, filed 9 May 2022.